Orthofix Historical Income Statement

OFIX Stock

USD 18.68 0.19 1.01%

Historical analysis of Orthofix Medical income statement accounts such as Income Tax Expense of 2.6 M can show how well Orthofix Medical performed in making a profits. Evaluating Orthofix Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Orthofix Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Orthofix Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Orthofix Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

About Orthofix Income Statement Analysis

Orthofix Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Orthofix Medical shareholders. The income statement also shows Orthofix investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Orthofix Medical Income Statement Chart

At this time, Orthofix Medical's Interest Expense is fairly stable compared to the past year. Total Revenue is likely to rise to about 784 M in 2024, whereas Gross Profit is likely to drop slightly above 259.2 M in 2024.

Interest Expense Total Revenue Gross Profit Other Operating Expenses Cost Of Revenue Research Development

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Orthofix Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Orthofix Medical minus its cost of goods sold. It is profit before Orthofix Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Orthofix Medical. It is also known as Orthofix Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Orthofix Medical income statement and represents the costs associated with goods and services Orthofix Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Orthofix Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Orthofix Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.At this time, Orthofix Medical's Interest Expense is fairly stable compared to the past year. Total Revenue is likely to rise to about 784 M in 2024, whereas Gross Profit is likely to drop slightly above 259.2 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	349.6M	337.2M	486.3M	259.2M
Total Revenue	464.5M	460.7M	746.6M	784.0M

Gross Profit Total Revenue

Orthofix Medical income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Operating Income	Ebit	Ebitda	Net Income	Income Tax Expense	Depreciation And Amortization	Other Operating Expenses	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Research Development	Selling General Administrative	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation
Interest Expense		0.71	0.35	-0.69	-0.47	-0.38	-0.71	-0.14	0.7	0.73	0.8	0.71	-0.68	-0.34	0.62	0.54	0.49	-0.69	0.17	-0.3	-0.37	0.22	-0.65	0.55
Total Revenue	0.71		0.73	-0.63	-0.57	-0.45	-0.69	0.12	0.85	0.96	0.93	0.96	-0.63	-0.2	0.85	0.59	0.83	-0.69	-0.09	-0.24	-0.4	0.13	-0.73	0.59
Gross Profit	0.35	0.73		-0.12	-0.07	0.04	-0.19	0.41	0.47	0.57	0.5	0.57	-0.13	-0.34	0.43	0.48	0.92	-0.18	-0.12	-0.03	-0.14	0.01	-0.24	0.37
Operating Income	-0.69	-0.63	-0.12		0.93	0.9	0.97	0.48	-0.8	-0.81	-0.86	-0.8	0.98	-0.13	-0.86	-0.72	-0.47	0.96	-0.03	0.39	0.56	-0.29	0.91	-0.82
Ebit	-0.47	-0.57	-0.07	0.93		0.99	0.89	0.45	-0.79	-0.76	-0.78	-0.77	0.91	-0.35	-0.87	-0.69	-0.44	0.92	0.04	0.3	0.55	-0.16	0.93	-0.82
Ebitda	-0.38	-0.45	0.04	0.9	0.99		0.86	0.49	-0.68	-0.67	-0.69	-0.68	0.88	-0.41	-0.79	-0.67	-0.33	0.88	0.07	0.27	0.5	-0.14	0.88	-0.77
Net Income	-0.71	-0.69	-0.19	0.97	0.89	0.86		0.38	-0.81	-0.84	-0.88	-0.84	0.99	0.01	-0.87	-0.74	-0.51	0.99	0.11	0.32	0.59	-0.24	0.9	-0.8
Income Tax Expense	-0.14	0.12	0.41	0.48	0.45	0.49	0.38		-0.2	-0.09	-0.13	-0.09	0.53	-0.06	-0.2	-0.3	0.13	0.38	-0.12	0.78	0.33	-0.51	0.35	-0.36
Depreciation And Amortization	0.7	0.85	0.47	-0.8	-0.79	-0.68	-0.81	-0.2		0.92	0.91	0.93	-0.8	0.04	0.94	0.59	0.71	-0.82	0.06	-0.35	-0.61	0.21	-0.89	0.78
Other Operating Expenses	0.73	0.96	0.57	-0.81	-0.76	-0.67	-0.84	-0.09	0.92		0.99	1.0	-0.8	-0.07	0.95	0.68	0.78	-0.84	-0.07	-0.33	-0.5	0.18	-0.87	0.73
Cost Of Revenue	0.8	0.93	0.5	-0.86	-0.78	-0.69	-0.88	-0.13	0.91	0.99		0.98	-0.85	-0.07	0.94	0.69	0.72	-0.89	-0.03	-0.34	-0.51	0.2	-0.9	0.75
Total Operating Expenses	0.71	0.96	0.57	-0.8	-0.77	-0.68	-0.84	-0.09	0.93	1.0	0.98		-0.8	-0.05	0.95	0.68	0.78	-0.84	-0.08	-0.33	-0.5	0.18	-0.88	0.73
Income Before Tax	-0.68	-0.63	-0.13	0.98	0.91	0.88	0.99	0.53	-0.8	-0.8	-0.85	-0.8		-0.01	-0.85	-0.74	-0.47	0.98	0.09	0.44	0.61	-0.31	0.9	-0.81
Total Other Income Expense Net	-0.34	-0.2	-0.34	-0.13	-0.35	-0.41	0.01	-0.06	0.04	-0.07	-0.07	-0.05	-0.01		0.16	-0.12	-0.17	-0.03	0.36	0.14	-0.07	-0.17	-0.25	0.22
Research Development	0.62	0.85	0.43	-0.86	-0.87	-0.79	-0.87	-0.2	0.94	0.95	0.94	0.95	-0.85	0.16		0.62	0.7	-0.88	-0.03	-0.33	-0.63	0.24	-0.94	0.83
Selling General Administrative	0.54	0.59	0.48	-0.72	-0.69	-0.67	-0.74	-0.3	0.59	0.68	0.69	0.68	-0.74	-0.12	0.62		0.7	-0.75	-0.24	-0.31	-0.29	0.15	-0.68	0.75
Selling And Marketing Expenses	0.49	0.83	0.92	-0.47	-0.44	-0.33	-0.51	0.13	0.71	0.78	0.72	0.78	-0.47	-0.17	0.7	0.7		-0.51	-0.07	-0.2	-0.39	0.11	-0.57	0.7
Net Income From Continuing Ops	-0.69	-0.69	-0.18	0.96	0.92	0.88	0.99	0.38	-0.82	-0.84	-0.89	-0.84	0.98	-0.03	-0.88	-0.75	-0.51		0.14	0.32	0.6	-0.24	0.93	-0.82
Non Operating Income Net Other	0.17	-0.09	-0.12	-0.03	0.04	0.07	0.11	-0.12	0.06	-0.07	-0.03	-0.08	0.09	0.36	-0.03	-0.24	-0.07	0.14		-0.15	-0.11	-0.13	-0.08	0.12
Tax Provision	-0.3	-0.24	-0.03	0.39	0.3	0.27	0.32	0.78	-0.35	-0.33	-0.34	-0.33	0.44	0.14	-0.33	-0.31	-0.2	0.32	-0.15		0.36	-0.67	0.37	-0.39
Interest Income	-0.37	-0.4	-0.14	0.56	0.55	0.5	0.59	0.33	-0.61	-0.5	-0.51	-0.5	0.61	-0.07	-0.63	-0.29	-0.39	0.6	-0.11	0.36		-0.17	0.6	-0.69
Extraordinary Items	0.22	0.13	0.01	-0.29	-0.16	-0.14	-0.24	-0.51	0.21	0.18	0.2	0.18	-0.31	-0.17	0.24	0.15	0.11	-0.24	-0.13	-0.67	-0.17		-0.2	0.28
Net Interest Income	-0.65	-0.73	-0.24	0.91	0.93	0.88	0.9	0.35	-0.89	-0.87	-0.9	-0.88	0.9	-0.25	-0.94	-0.68	-0.57	0.93	-0.08	0.37	0.6	-0.2		-0.87
Reconciled Depreciation	0.55	0.59	0.37	-0.82	-0.82	-0.77	-0.8	-0.36	0.78	0.73	0.75	0.73	-0.81	0.22	0.83	0.75	0.7	-0.82	0.12	-0.39	-0.69	0.28	-0.87

Click cells to compare fundamentals

Orthofix Medical Account Relationship Matchups

Orthofix Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	122K	2.5M	1.8M	1.3M	8.6M	9.1M
Total Revenue	460.0M	406.6M	464.5M	460.7M	746.6M	784.0M
Gross Profit	359.3M	304.7M	349.6M	337.2M	486.3M	259.2M
Operating Income	24.9M	1.6M	(6.2M)	(20.7M)	(139.1M)	(132.2M)
Ebit	24.9M	2.1M	(11.7M)	(16.4M)	(140.0M)	(133.0M)
Ebitda	49.6M	32.7M	17.9M	12.6M	(87.0M)	(82.6M)
Net Income	(28.5M)	2.5M	(38.4M)	(19.7M)	(151.4M)	(143.8M)
Income Tax Expense	1.4M	(2.9M)	24.9M	2.0M	2.7M	2.6M
Depreciation And Amortization	24.7M	30.5M	29.6M	29.0M	53.1M	55.7M
Other Operating Expenses	444.5M	413.3M	455.2M	481.4M	885.8M	930.0M
Cost Of Revenue	100.6M	101.9M	114.9M	123.5M	260.4M	273.4M
Total Operating Expenses	343.9M	311.4M	340.3M	357.8M	667.4M	700.8M
Income Before Tax	(27.0M)	(368K)	(13.5M)	(17.7M)	(148.7M)	(141.2M)
Total Other Income Expense Net	(52.0M)	(366.5K)	(5.2M)	(4.4M)	(9.6M)	(10.0M)
Research Development	34.6M	39.1M	49.6M	49.1M	80.2M	84.2M
Selling General Administrative	85.6M	67.9M	69.4M	80.0M	144.7M	87.6M
Net Income Applicable To Common Shares	(28.5M)	2.5M	(38.4M)	(19.7M)	(17.8M)	(16.9M)
Selling And Marketing Expenses	223.7M	204.4M	221.3M	228.8M	385.7M	198.7M
Net Income From Continuing Ops	(28.5M)	2.5M	(38.4M)	(19.7M)	(151.4M)	(143.8M)
Non Operating Income Net Other	(10.7M)	10.3M	(4.3M)	(2.8M)	(2.5M)	(2.6M)
Tax Provision	1.4M	(2.9M)	24.9M	2.0M	2.7M	2.6M
Net Interest Income	(122K)	(2.5M)	(1.8M)	(1.3M)	(8.6M)	(8.2M)
Reconciled Depreciation	24.7M	34.3M	33.1M	32.1M	60.6M	35.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Orthofix Historical Income Statement

About Orthofix Income Statement Analysis

Orthofix Medical Income Statement Chart

Interest Expense

Total Revenue

Gross Profit

Other Operating Expenses

Cost Of Revenue

Orthofix Medical income statement Correlations

Orthofix Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Orthofix Medical income statement Accounts

Also Currently Popular

Additional Tools for Orthofix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 0.99	Ebit
Income Before Tax	+ 0.99	Net Income
Net Income From Continuing Ops	+ 0.99	Net Income
Cost Of Revenue	+ 0.99	Other Operating Expenses
Income Before Tax	+ 0.98	Operating Income

Net Interest Income	- 0.94	Research Development
Net Interest Income	- 0.9	Cost Of Revenue
Net Income From Continuing Ops	- 0.89	Cost Of Revenue
Net Interest Income	- 0.89	Depreciation And Amortization
Net Income From Continuing Ops	- 0.88	Research Development
Net Interest Income	- 0.88	Total Operating Expenses